Karmanos Recognitions

Michigan Cancer Consortium

Michigan Cancer ConsortiumThe Barbara Ann Karmanos Cancer Institute is a member of the Michigan Cancer Consortium.

The MCC is a statewide, broad-based partnership that strives to include all interested public and private organizations and provides a forum for collaboration to reduce the burden of cancer among the citizens of Michigan by achieving the Consortium's research-based and results-oriented cancer prevention and control priorities. For more information visit the MCC website

Goals of Consortium and its members include:

  • Prevent cancer from occurring
  • Promote early detection of cancer using tests that have been shown to reduce mortality
  • Diagnose and treat all patients using the most effective and appropriate methods
  • Optimize quality of life for every person affected by cancer

The Latest From Karmanos Cancer Institute

News

Karmanos Cancer Institute announces additions to Board of Directors

The Barbara Ann Karmanos Cancer Institute is pleased to announce the appointment of two board of director members: Geaneen Arends, attorney and vi...

Read More

Enjoying the warm weather while undergoing cancer treatment

Summer is associated with sunny days, outdoor activities and long vacations. However, receiving a cancer diagnosis or undergoing treatment may cha...

Read More

Karmanos Cancer Institute and other top U.S. cancer centers call for urgent action to get cancer-preventing HPV vaccination back on track

The Barbara Ann Karmanos Cancer Institute has partnered with more than 70 other National Cancer Institute (NCI)-designated cancer centers and part...

Read More